Tom Roberts came to UCB Korea following a position at the company’s Japanese affiliate in late 2011. He describes the market conditions for UCB’s…

Mexico is improving its regulatory framework for orphan drugs. The general manager of Alexion Mexico explains how the company is working with the…

The country manager of a multinational keen to ramp up its activities in the local market discusses the strategic importance of the Algerian…

Medtronic’s Regional Director for the South Cone shares with us the story of the company’s impressive success since the rebirth of their…

The COO of Argentina’s largest logistics provider explains how the firm evolved into the preeminent player in the pharmaceutical logistics market,…

The vice president of Laboratorio Tuteur highlights the position of his company as the leaders in specialty products in Argentina. Could…

The global COO of the multinational at the forefront of the fight against diabetes explains why the Algerian market is so strategically important and…

Insights from existing players on what to expect and how to succeed in Algeria today. “The key to being successful is to be direct and forthright…

Mexico is one of GSK’s growth engines in Latin America. The VP and general manager for Mexico discusses how the country is increasingly playing a…

Oh Pil-Soo, managing director of Lundbeck Korea, talks about the challenges of pricing and reimbursement in the CNS area and remaining committed to…

The founder and president of Close Up International shares the story of the genesis, evolution, and growth of both his company and the prescription…

Brian Gladsden was appointed president of Novartis Korea in January 2014. He relates his previous experience to the market situation in Korea and…